Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.4
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
Research and development $ 22,107,563 $ 12,120,318
General and administrative 4,533,893 3,757,251
Total operating expenses 26,641,456 15,877,569
Loss from operations (26,641,456) (15,877,569)
Other income (expense):    
Interest income 89,294 320,011
Interest expense (10,685) (7,300)
Local business tax (2,400) (1,601)
Other income 1,795 456
Forgiveness of Paycheck Protection Program loan and accrued interest 132,753
Total other income (expense), net 210,757 311,566
Loss before income taxes (26,430,699) (15,566,003)
Income tax benefit
Net loss $ (26,430,699) $ (15,566,003)
Basic and diluted net loss per share $ (0.47) $ (0.37)
Shares used to compute basic and diluted net loss per share 56,531,246 42,283,947